tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LJUIF Stock Latest News

SSY Group’s Ambroxol Hydrochloride Gains Regulatory Approval in China
Company AnnouncementsSSY Group’s Ambroxol Hydrochloride Gains Regulatory Approval in China
15d ago
SSY Group Expands Pharmaceutical Portfolio with New Drug Approvals
PremiumCompany Announcements
SSY Group Expands Pharmaceutical Portfolio with New Drug Approvals
15d ago
SSY Group’s Indocyanine Green Gains Approval in China
PremiumCompany Announcements
SSY Group’s Indocyanine Green Gains Approval in China
21d ago
SSY Group Secures Approval for Seven New Pharmaceutical Products
PremiumCompany Announcements
SSY Group Secures Approval for Seven New Pharmaceutical Products
25d ago
SSY Group Gains Approval for Allopurinol Tablets in China
PremiumCompany Announcements
SSY Group Gains Approval for Allopurinol Tablets in China
29d ago
SSY Group Secures Key Drug Approvals in China
PremiumCompany AnnouncementsSSY Group Secures Key Drug Approvals in China
29d ago
SSY Group Faces Revenue Decline Amidst Challenging Market Conditions
Premium
Company Announcements
SSY Group Faces Revenue Decline Amidst Challenging Market Conditions
1M ago
SSY Group Limited Announces Interim Dividend for 2025
Premium
Company Announcements
SSY Group Limited Announces Interim Dividend for 2025
1M ago
SSY Group Secures Approval for New Hypertension Drug
PremiumCompany Announcements
SSY Group Secures Approval for New Hypertension Drug
1M ago
SSY Group’s Morinidazole Receives Approval for Market Launch
PremiumCompany Announcements
SSY Group’s Morinidazole Receives Approval for Market Launch
1M ago
SSY Group to Review Interim Financial Results and Dividend
PremiumCompany Announcements
SSY Group to Review Interim Financial Results and Dividend
1M ago
SSY Group’s Azilsartan Gains Approval in China
PremiumCompany Announcements
SSY Group’s Azilsartan Gains Approval in China
2M ago
SSY Group’s Fampridine Receives Regulatory Approval in China
PremiumCompany AnnouncementsSSY Group’s Fampridine Receives Regulatory Approval in China
2M ago
SSY Group’s Drotaverine Hydrochloride Gains Approval in China
Premium
Company Announcements
SSY Group’s Drotaverine Hydrochloride Gains Approval in China
2M ago
SSY Group Gains Approval for New Drug Production in China
Premium
Company Announcements
SSY Group Gains Approval for New Drug Production in China
2M ago
SSY Group Expands Pharmaceutical Portfolio with New Drug Approvals
PremiumCompany Announcements
SSY Group Expands Pharmaceutical Portfolio with New Drug Approvals
2M ago
SSY Group’s Cupric Chloride Gains Regulatory Approval in China
PremiumCompany Announcements
SSY Group’s Cupric Chloride Gains Regulatory Approval in China
3M ago
SSY Group Gains Approval for New Drug Injections in China
PremiumCompany Announcements
SSY Group Gains Approval for New Drug Injections in China
3M ago
SSY Group Advances Innovative Drug Development with Promising Trial Results
PremiumCompany Announcements
SSY Group Advances Innovative Drug Development with Promising Trial Results
3M ago
SSY Group Gains Exclusive Approval for Children’s Paracetamol Granules in China
PremiumCompany AnnouncementsSSY Group Gains Exclusive Approval for Children’s Paracetamol Granules in China
3M ago
SSY Group Gains Approval for Furosemide Tablet Production
Premium
Company Announcements
SSY Group Gains Approval for Furosemide Tablet Production
3M ago
SSY Group Secures Approval for New Respiratory Drugs
Premium
Company Announcements
SSY Group Secures Approval for New Respiratory Drugs
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >